Table: begin end state 1 16 cytoplasmic 17 38 transmembrane 39 44 non-cytoplasmic 45 67 transmembrane 68 89 cytoplasmic 90 118 transmembrane 119 129 non-cytoplasmic 130 149 transmembrane 150 160 cytoplasmic 161 180 transmembrane 181 194 non-cytoplasmic 195 215 transmembrane 216 230 cytoplasmic 231 253 transmembrane 254 276 non-cytoplasmic 277 300 transmembrane 301 329 cytoplasmic 330 348 transmembrane 349 353 non-cytoplasmic 354 373 transmembrane 374 384 cytoplasmic 385 405 transmembrane 406 410 non-cytoplasmic 411 431 transmembrane 432 445 cytoplasmic
Input: >N515DRAFT_4009 FitnessBrowser__Dyella79:N515DRAFT_4009 MSDTPASGYMRRLTSWDAAMIVVGGIIGGGIFLNPGIAAQRTESGLALLLVWVGAGVLTL IGALCYAELGARRPHAGGSYVYLREAFGSLAGFLFGWTMLLVIYSGSAAAVATIFASYAS GVFGLPPGTIKPLAAGALVFVAGINLFGLKLGAQVQNLFTLLKLLAVAVLVVCGLFLAGA DGAGVLASDPARGNVGFIGAALPVLFAYSGFTYLNNLAGEVREPQRTLPRALFFGMLAVI VVYALVNVAYLAVLGHDGLARSNTPAADVMSRVFGPIGAKVIAIGIAVSTLGFCNITLVA GARVLQVMGDDGLFFRNVARLHPRHRTPNVALLLLSGWAVFLAMAFNFGQLLDYATFGDW LACAVGVVTIFWYRSRDKGGADFRVPGYPVLPLIFVGVVGWIVVATLLAKPIQACIVLAV MAVGIPVFHVWRRMFPASALPSQSP
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server